- Eli Lilly press release (NYSE:LLY): Q2 Non-GAAP EPS of $6.31 beats by $0.72.
- Revenue of $15.56B (+37.7% Y/Y) beats by $890M.
- Revenue in Q2 2025 increased 38% to $15.56 billion driven by volume growth from Zepbound and Mounjaro.
- FY25 revenue
Eli Lilly Non-GAAP EPS of $6.31 beats by $0.72, revenue of $15.56B beats by $890M

Related
Ousted vaccine regulator Vinay Prasad to return to FDA
6 hours ago
2
White House crypto adviser Bo Hines announces departure
10 hours ago
0
Trending
Popular
اعزام اورژانس هرمزگان به مرز شلمچه
6 days ago
3
© FBT Company 2025. All rights are reserved